ArticleRenal failure2022

Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study.

Ekaterina Parshina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.